These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2546129)

  • 21. Neonatal 5,7-DHT lesions upregulate [3H]mesulergine-labelled spinal 5-HT1C binding sites in the rat.
    Pranzatelli MR
    Brain Res Bull; 1990 Jul; 25(1):151-3. PubMed ID: 2207701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intracerebroventricular administration of 5,7-dihydroxytryptamine to mice increases both head-twitch response and the number of cortical 5-HT2 receptors.
    Heal DJ; Philpot J; Molyneux SG; Metz A
    Neuropharmacology; 1985 Dec; 24(12):1201-5. PubMed ID: 4094656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of chronic treatment with 5-hydroxytryptophan on cortical serotonin receptors in the rat.
    Pranzatelli MR
    Clin Neuropharmacol; 1988 Jun; 11(3):257-62. PubMed ID: 3261199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Supersensitivity to L-5-hydroxytryptophan after 5,7-dihydroxytryptamine injections in desmethylimipramine- and nomifensine-pretreated rats: behavioral evidence for postsynaptic supersensitivity.
    Ortmann R; Martin S; Waldmeier PC
    Psychopharmacology (Berl); 1981; 74(2):109-14. PubMed ID: 6115443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimyoclonic properties of S2 serotonin receptor antagonists in the rat.
    Pranzatelli MR; Snodgrass SR
    Neuropharmacology; 1986 Jan; 25(1):5-12. PubMed ID: 2936977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 1-5-Hydroxytryptophan-induced flat body posture in the rat: antagonism by ritanserin and potentiation after 5,7-dihydroxytryptamine.
    Colpaert FC; Koek W; Lategan A
    Eur J Pharmacol; 1989 Oct; 169(1):175-8. PubMed ID: 2513211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of p-chloroamphetamine and 5,7-dihydroxytryptamine on rotation and dopamine turnover.
    Giambalvo CT; Snodgrass SR
    Brain Res; 1978 Jun; 149(2):453-67. PubMed ID: 566608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early postnatal administration of 5,7-DHT: effects on serotonergic neurons and terminals.
    Towle AC; Breese GR; Mueller RA; Coyle S; Lauder JM
    Brain Res; 1984 Sep; 310(1):67-75. PubMed ID: 6383521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alterations in 8-hydroxy-2-(dipropylamino)tetralin-induced neuroendocrine responses after 5,7-dihydroxytryptamine-induced denervation of serotonergic neurons.
    Van de Kar LD; Li Q; Cabrera TM; Brownfield MS; Battaglia G
    J Pharmacol Exp Ther; 1998 Jul; 286(1):256-62. PubMed ID: 9655867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5-HT depletion with 5,7-DHT, PCA and PCPA in mice: differential effects on the sensitivity to 5-MeODMT, 8-OH-DPAT and 5-HTP as measured by two nociceptive tests.
    Eide PK; Hole K; Berge OG; Broch OJ
    Brain Res; 1988 Feb; 440(1):42-52. PubMed ID: 2965956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5-HT2 receptors, roles and regulation.
    Leysen JE; Pauwels PJ
    Ann N Y Acad Sci; 1990; 600():183-91; discussion 192-3. PubMed ID: 2252309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemical and behavioral alterations in developing rats treated with 5,7-dihydroxytryptamine.
    Breese GR; Vogel RA; Mueller RA
    J Pharmacol Exp Ther; 1978 Jun; 205(3):587-95. PubMed ID: 307057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Receptor mechanisms in increased sensitivity to serotonin agonists after dihydroxytryptamine shown by electronic monitoring of muscle twitches in the rat.
    Stewart RM; Campbell A; Sperk G; Baldessarini RJ
    Psychopharmacology (Berl); 1979 Feb; 60(3):281-9. PubMed ID: 108706
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacological evidence of supersensitivity of central serotonergic receptors involved in the control of prolactin secretion.
    Quattrone A; Schettini G; Annunziato L; Di Renzo G
    Eur J Pharmacol; 1981 Nov; 76(1):9-13. PubMed ID: 7318925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics of central 5-HT receptors and their adaptive changes following intracerebral 5,7-dihydroxytryptamine administration in the rat.
    Nelson DL; Herbet A; Bourgoin S; Glowinski J; Hamon M
    Mol Pharmacol; 1978 Nov; 14(6):983-95. PubMed ID: 732817
    [No Abstract]   [Full Text] [Related]  

  • 36. Increased tryptophan hydroxylase activity in serotonergic nerve terminals spared by 5,7-dihydroxytryptamine.
    Stachowiak MK; Stricker EM; Jacoby JH; Zigmond MJ
    Biochem Pharmacol; 1986 Apr; 35(8):1241-8. PubMed ID: 2421731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regional central serotonin receptor binding in rats treated chronically with high-dose 5-hydroxy-L-tryptophan.
    Pranzatelli MR
    Exp Brain Res; 1991; 87(2):340-4. PubMed ID: 1769387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alterations in serotonin binding sites after 5,7-dihydroxytryptamine treatment in the rat spinal cord.
    Brown LM; Smith DL; Williams GM; Smith DJ
    Neurosci Lett; 1989 Jul; 102(1):103-7. PubMed ID: 2779841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serotonin turnover and supersensitivity after neonatal 5,7-dihydroxytryptamine.
    Mueller RA; Towle A; Breese GR
    Pharmacol Biochem Behav; 1985 Feb; 22(2):221-5. PubMed ID: 2580321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biochemical and behavioral effects of serotonin neurotoxins on the nigrostriatal dopamine system: comparison of injection sites.
    Giambalvo CT; Snodgrass SR
    Brain Res; 1978 Sep; 152(3):555-66. PubMed ID: 308384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.